- Lobbying
- Lobbying by 1776 Pharmaceuticals LLC
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Muftiah McCartin | House Rules Committee, Staff Director, Deputy Staff Director; General Counsel (Detailed), House Select Committee on Voting Irregularities; House Committee on Appropriations, Professional Staff, House Office of Parliamentarian, Assoc., Asst., Clerk |
Broderick Johnson | Assistant to the President and Cabinet Secretary, the White House (20014-2017); Deputy Assistant to the President for Legislative Affairs, the White House (1998-2000) |
Layth Elhassani | White House Off. Leg. Aff., Sp. Assist. to the President; Off. of Sen. Bennet, Leg. Dir.; House Comm. on Small Business, Oversight Counsel; Off. of Rep. Velazquez, Leg. Dir.; Off. of Sen. Cantwell, Leg. Counsel; Off. of Sen. Hollings, Legal Counsel |
Howard Berman | Member, United States House of Representatives |
Gary Heimberg | n/a |
Joan Kutcher | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Manufacturing
Pharmacy
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Manufacturing
Pharmacy
Registration
Issue(s) they said they’d lobby about: Re-shoring production of essential medicine.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate